LEP and breast cancer: Leptin signaling could play an important role in the growth of highly invasive, metastatic, and more deadly estrogen receptor-negative (ER-) BC cells that do not respond to endocrine therapy and are mostly treated with chemotherapeutics that exhibit several detrimental side effects [20].